New combo aims to ease pain in newborn surgery
NCT ID NCT07609836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding dexamethasone to the standard painkiller bupivacaine improves pain relief for newborns undergoing inguinal hernia repair. 150 full-term infants will be randomly assigned to receive either the combination or bupivacaine alone via a caudal injection. Pain will be measured using the FLACC scale for 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexamethasone added to bupivacaine
- What this could lead to
- If it works, this could provide better pain control for newborns after hernia surgery, reducing their discomfort.
- What could go wrong
- This is a small, early-stage study with no phase assigned. The added dexamethasone may not improve pain relief and could carry risks like infection or delayed healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WE ARE STUDYING THE EFFECTS OF CAUDAL DEXAMETHASONE IN NEONATES UNDERGOING INGUINAL HERNIA REPAIR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.